<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Jubilee Medical Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Jubilee Medical Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=130400000&amp;denomIds=13.4&amp;selectedTab=summary">Other topical corticosteroid preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Topical corticosteroids</td>
      <td>884</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>9.21</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=130400000AABLBL&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Propylene glycol 40% in Clobetasol 0.05% cream : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=1302010N0&amp;denomIds=13.2.1&amp;selectedTab=summary">Paraffin soft white</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Emollients</td>
      <td>265</td>
      <td>0.03</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>5.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=1302010N0AAAAAA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin solid : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040S0&amp;denomIds=2.5.4&amp;selectedTab=summary">Prazosin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>33</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>615</td>
      <td>0.05</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>4.07</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040S0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Prazosin 500microgram tablets : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040S0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Prazosin 1mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=1302010E0&amp;denomIds=13.2.1&amp;selectedTab=summary">Dexpanthenol</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Emollients</td>
      <td>265</td>
      <td>0.03</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>3.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=1302010E0BBACAC&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Bepanthen Nappy Care 5% ointment : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0606020Y0&amp;denomIds=6.6.2&amp;selectedTab=summary">Alendronic acid/colecalciferol</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>15</td>
      <td>Bisphosphonates and other drugs</td>
      <td>811</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>3.38</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0606020Y0BBAAAA&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Fosavance tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0606020Y0AAAAAA&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 70mg / Colecalciferol 70microgram tablets : 12</a></div></td></tr></tbody></table>

        <h2>Prescribing where Jubilee Medical Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0&amp;denomIds=2.5.4&amp;selectedTab=summary">Doxazosin mesilate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>565</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>615</td>
      <td>0.92</td>
      <td>0.99</td>
      <td>0.02</td>
      <td>-3.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AAAAAA&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 1mg tablets : 51</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 2mg tablets : 148</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg tablets : 297</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AAAQAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg modified-release tablets : 53</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AABBBB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0205040D0AAARAR&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg modified-release tablets : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0409020S0&amp;denomIds=4.9.2&amp;selectedTab=summary">Procyclidine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Antimuscarinic drugs used in parkinsonism</td>
      <td>27</td>
      <td>0.37</td>
      <td>0.84</td>
      <td>0.21</td>
      <td>-2.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0409020S0BCAAAE&amp;denomIds=4.9.2&amp;selectedTab=summary" target="_blank">Kemadrin 5mg tablets : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0901020G0&amp;denomIds=9.1.2&amp;selectedTab=summary">Folic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>609</td>
      <td>Drugs used in megaloblastic anaemias</td>
      <td>1426</td>
      <td>0.43</td>
      <td>0.70</td>
      <td>0.16</td>
      <td>-1.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0901020G0AAAGAG&amp;denomIds=9.1.2&amp;selectedTab=summary" target="_blank">Folic acid 5mg tablets : 604</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0901020G0AACICI&amp;denomIds=9.1.2&amp;selectedTab=summary" target="_blank">Folic acid 2.5mg/5ml oral solution sugar free : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0901020G0AABFBF&amp;denomIds=9.1.2&amp;selectedTab=summary" target="_blank">Folic acid 400microgram tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0&amp;denomIds=3.2&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>685</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1827</td>
      <td>0.37</td>
      <td>0.57</td>
      <td>0.12</td>
      <td>-1.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 inhaler : 69</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJAFBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100micrograms/dose Easi-Breathe inhaler : 32</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BPAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 50micrograms/dose inhaler : 32</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BPABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 100micrograms/dose inhaler : 153</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BPACBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 200micrograms/dose inhaler : 71</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BQAABX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 100micrograms/dose / 6micrograms/dose inhaler : 200</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BQABBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 200micrograms/dose / 6micrograms/dose inhaler : 30</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0AABVBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200micrograms/dose inhaler CFC free : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0AABFBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100micrograms/dose inhaler CFC free : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 inhaler : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJADBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 Autohaler : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BRAABY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJAEBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50micrograms/dose Easi-Breathe inhaler : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BJACBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 Autohaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BRABCA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0AABEBE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 50micrograms/dose inhaler CFC free : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0AABHBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100mcg/dose breath actuated inhaler CFC free : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0BPADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 250micrograms/dose inhaler : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0302000C0AABXBX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 19</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0&amp;denomIds=2.12&amp;selectedTab=summary">Atorvastatin</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4541</td>
      <td>Lipid-regulating drugs</td>
      <td>8389</td>
      <td>0.54</td>
      <td>0.66</td>
      <td>0.08</td>
      <td>-1.47</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 10mg tablets : 719</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 20mg tablets : 1667</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAACAC&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 40mg tablets : 1564</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAADAD&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 80mg tablets : 564</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAANAN&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 30mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0BBACAC&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 40mg tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0BBAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 10mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0BBABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 20mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82097&amp;numIds=0212000B0AAAPAP&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 60mg tablets : 10</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>